Overview

Safety and Efficacy of Bimatoprost Ophthalmic Solution in Increasing Eyelash Prominence

Status:
Completed
Trial end date:
2010-07-01
Target enrollment:
Participant gender:
Summary
This study will evaluate the safety and efficacy of bimatoprost ophthalmic solution 0.005% or 0.015% compared with bimatoprost ophthalmic solution 0.03% once-daily application to the upper eyelid margins in increasing eyelash prominence
Phase:
Phase 2
Details
Lead Sponsor:
Allergan
Treatments:
Bimatoprost
Ophthalmic Solutions
Pharmaceutical Solutions